Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mtbvac (1 trial)
gla-se (1 trial)
id93 (1 trial)
Latent Tuberculosis (Phase 2)
Tuberculosis (Phase 2)
Tuberculosis, Pulmonary (Phase 1)
Trials (2 total)
Trial APIs (3 total)